
Longwood Fund creates and invests in science‑based healthcare companies, leveraging deep company‑building experience to translate breakthrough discoveries into therapies. They partner with world‑class scientists, entrepreneurs and academic innovators to launch and grow novel biotech and healthtech ventures. The fund focuses on building enduring value for patients and investors by supporting companies from inception through later‑stage growth.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
United States
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
58.3%United Kingdom
19.4%Australia
2.8%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Series A → Series C+
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Fund VI
Vintage 2023 • $180.0M
Fund V
Vintage 2020 • $170.0M